Back to company

mAbSolution IVS: Financial statements 2016

CVR: 36893729

mAbSolution IVS (CVR 36893729) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -7,600 and a net result of DKK -7,612. Equity amounted to DKK -9,862.

Gross Profit
-7,600 kr.
Profit/Loss
-7,612 kr.
Equity
-9,862 kr.
Total Assets
2,388 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is mAbSolution IVS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

Lars Nørgaard steps down as director of mAbSolution IVSDec 7, 2016

As of December 7, 2016, Lars Nørgaard has stepped down as director of mAbSolution IVS.

MAbSolution IVS publishes interim reportJun 17, 2016

MAbSolution IVS has published its interim report for the period May 13, 2015 – December 31, 2015.

About mAbSolution IVS

mAbSolution IVS was a Danish company of the type Iværksætterselskab based in Kgs. Lyngby, founded in 2015 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK -13,668 and a net result of DKK -13,668 compared with DKK -7,612 the year before. Equity amounted to DKK -33,920.

Other financial years